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In vitro fabrication of functional vascularized three-dimensional tissues has been a long-
standing objective in the field of tissue engineering. Here we report a technique to engineer
cardiac tissues with perfusable blood vessels in vitro. Using resected tissue with a con-
nectable artery and vein as a vascular bed, we overlay triple-layer cardiac cell sheets pro-
duced from coculture with endothelial cells, and support the tissue construct with media
perfused in a bioreactor. We show that endothelial cells connect to capillaries in the vascular
bed and form tubular lumens, creating in vitro perfusable blood vessels in the cardiac cell
sheets. Thicker engineered tissues can be produced in vitro by overlaying additional triple-
layer cell sheets. The vascularized cardiac tissues beat and can be transplanted with blood
vessel anastomoses. This technique may create new opportunities for in vitro tissue
engineering and has potential therapeutic applications.
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S
tem cell technology and tissue engineering have developed
side by side and have the potential to lead to regenerative
therapies for the treatment of many patients suffering from
various diseases. As Langer and Vacanti reported the fabrication
of cartilage tissue in the shape of an ear by seeding cell
suspensions onto a three-dimensional (3-D) biodegradable
polymer scaffold, scaffold-based tissue engineering has rapidly
spread around the world1–3. This technology has already been
used for several clinical applications of bioengineered tissues,
including bone, cartilage, skin and large blood vessels4–6. On the
other hand, we have developed cell-sheet-based tissue
engineering, which utilizes two-dimensional (2-D) contiguous
monolayer cells in a cell sheet collected from a temperature-
responsive culture surface7,8. The cell sheet is easily transferred
onto damaged organs and 3-D tissues are bioengineered simply
by stacking the 2-D cell sheets. Clinical applications to date
include oral mucosal epithelial cell sheets transplanted to repair
damage from cornea and oesophagus diseases, and myoblast
sheets have been implanted to treat severe heart failure9–11.
Furthermore, synchronously pulsatile myocardial tissues have
been successfully fabricated by stacking rat cardiac cell sheets12.
Both of these technologies have realized native tissue-like 3-D
structures; however a long-standing critical obstacle in tissue
engineering is the formation of perfusable blood vessels in vitro
for oxygen and nutrient supply, and waste removal. Usually,
in vivo host-originated blood vessel formation is to be expected,
but primary ischaemia before sufficient neovascularization limits
the viability and thickness of engineered tissue13. In vitro
endothelial cell (EC) coculture has been a recent focus and
reported to enhance in vivo vascular formation. However, the
effectiveness is limited by the immature structure of in vitro
cultured ECs, because they only produce EC networks with a
partial tubular structure. After all, the thickness of viable tissue is
limited by the time period for in vivo vascular maturation and
connexion with the host blood vessels. Therefore, new techniques
for in vitro formation of mature blood vessels with continuous
media-perfusable lumens is critical for the future development of
tissue engineering.
Here we demonstrate a technology for in vitro fabrication of
functional 3-D tissues with perfusable blood vessels. In vitro
engineered tissue survived after transplantation by successfully
connecting to the host blood vessels.
Results
Vascular bed preparation in a perfusion bioreactor system. To
mimic in vivo conditions, cardiac cell sheets cocultured with ECs
were transferred onto a vascular bed using a resected section of
femoral tissue containing a connectable artery and vein, which
was then perfused with culture medium in vitro. We hypothesized
that the cocultured ECs could form new blood vessels that would
connect with the blood vessels originating from the vascular bed,
so that media supplied through these newly formed vessels would
allow the cell sheet constructs to survive (Fig. 1a).
To obtain a vascular bed with a complete arterio-venous (AV)
loop, rat femoral muscle tissue, including branches of the femoral
artery and vein, was partially resected from the surrounding tis-
sues and peripheral blood vessels. The tissue with the artery and
vein was then immediately returned to its original position and
incubated in the host body for 1 week. After remodelling of the
tissue and blood vessel networks, the whole construct, including
the femoral artery and vein, was resected from the rat. Then, the
construct was placed in a tissue culture chamber to become a
vascular bed and the femoral vessels were connected to two thin
polyurethane tubes for the culture media perfusion (Fig. 1b). The
vascular bed was perfused with culture media, which included 6%
fetal bovine serum from the inlet tube connecting to the femoral
artery. The media pH (7.4) and perfusion rate (50 ml min 1) were
maintained in a steady state by gas and pump controllers,
respectively. In addition, the inlet pressure (49±26mmHg) and
the outlet waste media volume (47±15% of perfused media) were
continuously monitored. Although significant volume of the
media exuded from the tissue surface, it is a natural phenomenon
as observed with in vivo intestinal fluids, which are usually
returned to vein or lymph vessels under closed conditions. Using
this bioreactor system, the tissues, including the AV networks
were continuously perfused as a vascular bed.
Tight connection of cardiac cell sheets on the vascular bed.
Next, neonatal rat cardiac cells, with or without ECs, were cul-
tured on temperature-responsive culture dishes. After a 4-day
culture, confluent cells were harvested as 2-D contiguous cell
sheets from the dishes only by lowering the temperature. As
previously reported, cocultured cell sheets maintained their pre-
vascular EC networks14,15. Three cell sheets were stacked
together, and then the triple-layered tissue was overlaid on the
vascular bed in the bioreactor system; because three layers is the
thickness limit for layered cell sheets without blood vessels.
Biological extracellular proteins remain underneath the cell
sheets, even after detachment from the culture dishes, and this
realized a tight and rapid adhesion not only between each cell
sheet, but also between the cell sheet and the vascular bed16.
Therefore, these tightly connected tissues were able to be
continuously cultivated in vitro without any delamination.
In vitro perfusable blood vessel formation. By using this
bioengineered tissue culture system, we compared the perfusable
blood vessel formation among four groups (each n¼ 4), with and
without EC coculture, and with or without the addition of
fibroblast growth factor 2 (FGF-2) in the perfusion media. FGF-2
is well-known as an accelerator of neovascularization17. After a
3-day culture, black ink was perfused through the constructs and
fixed for histological analyses. Haematoxilin and eosin (HE)
staining of black ink-perfused tissues demonstrated that there was
no luminal structure nor any ink detected within the cell sheet
layers in the non-coculture groups, regardless of FGF-2
administration (Fig. 2a,b). In the case of cocultured constructs
without FGF-2 perfusion, significant tubular structure was
observed within the constructs; however, there was hardly any
ink detected within the structure (Fig. 2c). On the other hand, in
the case of FGF-2-treated, cocultured constructs, the black ink
reached well within the tubular structure of the cell sheet layers
and perfused throughout the constructs (Fig. 2d). The infused
black ink was thoroughly perfused and successfully returned to
the outlet. EC staining also revealed that there was no blood vessel
structure within the non-cocultured cardiac tissues (Fig. 2e,f), but
that many tubular blood vessel structures were formed within the
cardiac tissues cocultured with ECs (Fig. 2g,h). These data
confirmed that cocultured ECs contribute to blood vessel tubular
structure formation within the cell sheet constructs, and that
FGF-2 promotes perfusable blood vessel communication between
the constructs and the vascular bed.
Cell sheet survival via functional blood vessels. We also
examined the media supply to cell sheet layers and their viability
among the same four groups (each n¼ 4) using a luciferin-luci-
ferase bioluminescent imaging system. Cocultured or non-
cocultured cardiac cell sheets were fabricated from luciferase-
transgenic rat hearts, and triple-layer constructs were overlaid on
the vascular bed in the bioreactor system. After a 3-day perfusion
culture, with or without FGF-2 administration, luciferin was
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continuously infused from the artery side and when it reached the
cell sheets it promptly displayed luminescence. The early biolu-
minescence increasing state indicated that the media supply
process includes both direct media perfusion via the blood vessel
structure and media diffusion through the tissues. On the other
hand, the late plateau state represented the total viability of the
survived cardiac tissues. Captured bioluminescent images showed
an earlier start of signals and higher signals at 45min after
luciferin infusion in the two groups with EC coculture compared
with the two groups without coculture (Fig. 2i–n; Supplementary
Movie 1). This indicated that luciferin directly reached the con-
structs via the blood vessel structure in the coculture cases,
whereas luciferin diffused from the blood vessels of the vascular
bed and slowly reached the tissues in the non-coculture cases.
Furthermore, the increasing rate was steeper in the FGF-2-treated
case than in the non-treated case (Fig. 2m). Consistent with the
histological analyses, FGF-2 accelerated functional communica-
tions between the newly formed capillaries within the cocultured
tissues and the pre-existing blood vessels within the vascular bed,
leading to faster media perfusion. In the non-coculture cases,
cultivation with FGF-2 also tended to initiate a faster increase of
the signals than that without FGF-2, so that the final tissue
viability was comparative with the cocultured constructs. It was
considered that FGF-2 might have an effect on the blood vessel
structure within the vascular bed and promote media diffusion
from the bed to the non-vascularized cell sheet layers, supporting
the survival of triple-layer constructs, which are at the limit of
thickness without blood vessels. Statistically, FGF-2-treated,
cocultured constructs showed significantly higher signals both at
45 and 90min, compared with the non-FGF-2-treated, non-
cocultured constructs (Fig. 2n,o). These morphological and luci-
ferin infusion analyses confirmed that the combination of EC
coculture and FGF-2 perfusion culture realized in vitro perfusable
blood vessel formation, which contributes to the in vitro survival
of 3-D tissues. Furthermore, the media-perfused cardiac tissues
presented synchronous pulsation in vitro (Supplementary Movie
2), as well as the characteristic morphology of native heart tissue,
including well-differentiated sarcomeres (Fig. 2p).
Contribution of ECs to blood vessel formation. Next we
examined the contribution of cocultured ECs by using green
fluorescence protein (GFP)-expressing ECs. Scanning 2-D fluor-
escent images were obtained after the cocultured constructs were
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Figure 1 | In vitro engineering of functional 3-D tissue with perfusable blood vessels. (a) To engineer cell sheet constructs with perfusable blood
vessels, EC cocultured cardiac cell sheets are stacked, and then overlaid on a vascular bed in vitro. After appropriate perfusion using a bioreactor, the
cocultured ECs formed new blood vessels and connected with the blood vessels that originated from the vascular bed. Finally, the cell sheet constructs
survive via the media supplied through the new vessels that formed in vitro. (b) The engineered constructs are perfused in a custom-made bioreactor. The
bioreactor is a one-pass system consisting of a delivery pump, a custom-made tissue culture chamber, pH transmitter, flow transmitter, pressure
transmitter, CO2 gas source, process controller and data acquisition system. The construct is placed in the tissue culture chamber to become a vascular
bed and the femoral vessels are connected to two micro polyurethane tubes for culture media perfusion. The flow is generated by a delivery pump
from the media reservoir monitored by a pressure sensor positioned on the arterial inlet side, passing through the tissue culture chamber to exit into a
waste fluid tank. The pH is measured and controlled via a process controller to verifying the concentration of CO2 gas. The pH, temperature and arterial
pressure sensors are connected to the computer via a process controller.
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finally perfused with red fluorescent dextran (Fig. 3a). Without
FGF-2 treatment, GFP-positive EC networks were maintained
within the cell sheets, but dextran was hardly observed in the cell
sheets (Fig. 3b–d; Supplementary Movie 3). By contrast, FGF-2
treatment allowed significant red fluorescent dextran to pass
through the GFP-positive EC tubular structures (Fig. 3e–g;
Supplementary Movie 4). In another experiment, we perfused
4-mm-diameter red fluorescent spheres which similarly revealed
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many of the microspheres in the GFP-positive blood vessels
of the FGF-2-treated constructs (Fig. 3h–j; Supplementary Movie
5). Furthermore, in the FGF-2-treated case, cross-sectional
fluorescent images, which can differentiate between blood
vessels that originated from both the cell sheet and the vascular
bed, clearly shows migration of cocultured GFP-positive ECs
1
2
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Figure 3 | Contribution of cocultured ECs within the construct. (a) Scanning two-dimensional fluorescent images of the constructs containing cocultured
green fluorescence protein (GFP)-expressing ECs were obtained after the constructs were perfused with red fluorescent dextran. Three xy images at
different depths of the cell sheet (CS) regions (b, e and h), border region (c, f and i) and vascular bed (VB) region (d, g and j) are presented. (b–d) Without
FGF-2 treatment, the GFP-positive EC networks remain within the cell sheets, but dextran is hardly observed within the cell sheets. (e–g) In the case of
FGF-2-treated constructs, red fluorescent dextran passed through the GFP-positive EC tubular structures. (h–j) When 4-mm-diameter red fluorescent
spheres were perfused, many microspheres were observed in the GFP-positive blood vessels of the cell sheets when treated withFGF-2.
(k) Immunostaining with CD31 (red: all ECs) and GFP (green: ECs originated from the cell sheet) demonstrated that cocultured ECs migrated into the
vascular bed and connected to the blood vessels within the bed. An arrow indicates the communication between migrating ECs originated from the cell
sheet and vascular bed originated ECs. (l) Fused blood vessels containing both vascular bed (red) and cell sheet (green)-derived ECs were present in the
vascular bed. (m) By contrast, when GFP-negative cell sheets were overlaid on the GFP-expressing vascular bed, GFP-positive cells never migrated into the
cell sheet layers.
Figure 2 | Perfusable blood vessel formation and viable cardiac tissue fabrication. Blood vessel formation and tissue viability were evaluated
among the four groups, with and without EC coculture, and with or without FGF-2 administration in the perfusion medium. Each group was indicated as EC
( ) FGF ( ), EC ( ) FGF (þ ), EC (þ ) FGF ( ) and EC (þ ) FGF (þ ). (a–d) HE staining after a 3-day perfusion culture. Neither a luminal structure
nor perfused black ink were detected in either the EC ( ) FGF ( ) group or in the EC ( ) FGF (þ ) group. In the EC (þ ) FGF ( ) group,
a luminal structure was observed, but the black ink was hardly detected within it. In the EC (þ ) FGF (þ ) group, the infused black ink thoroughly reached
the blood vessel structure within cell sheet layers (red arrows). (e–h) CD31 staining for ECs. No blood vessel structure was observed within the cell sheet
layers in either the EC ( ) FGF ( ) group or the EC ( ) FGF (þ ) group. Significant tubular blood vessel structures (white arrows) were observed
in the EC (þ ) FGF ( ) group and in the EC (þ ) FGF (þ ) group. cell sheet (CS) indicates cell sheet constructs and vascular bed (VB) indicates vascular
beds. (i–o) Luciferase-expressing triple-layer cell sheets were overlaid on the vascular beds. After continuous luciferin infusion, serial bioluminescent
imaging of each group was analysed. The images captured at 45min are shown (i–l). Representative dynamic tracing is demonstrated (m). The
bioluminescent intensity at 45 and 90min is shown (n,o). The intensity increased in the early phase in the EC (þ ) FGF ( ) group and the EC (þ ) FGF
(þ ) group. On the other hand, it increased in the late phase in the EC ( ) FGF ( ) group and the EC ( ) FGF (þ ) group. FGF-2 accelerated the
increasing rate, regardless of EC coculture. Data are shown as mean±s.d. (*Po0.05) (n¼4). (p) Sarcomeric a-actinin staining (red) with nuclei staining
(blue) revealed well-differentiated sarcomeres within the cell sheet construct in the EC (þ ) FGF (þ ) group. (q) HE staining showed that perfused black
ink is occasionally detected EC(þ ) FGF( ) group.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2406 ARTICLE
NATURE COMMUNICATIONS | 4:1399 | DOI: 10.1038/ncomms2406 |www.nature.com/naturecommunications 5
& 2013 Macmillan Publishers Limited. All rights reserved.
into the vascular bed and directly communicating chimerical
blood vessels (Fig. 3k,l). By contrast, when the GFP-negative
cell sheet layers were overlaid on a GFP-expressing vascular
bed, GFP-positive cells hardly migrated into the cell sheet con-
structs (Fig. 3m). These data indicated that prevascular endo-
thelial networks migrate into the vascular bed and connect to
the blood vessels originating from the bed, leading to the for-
mation of functional tubular blood vessels in the culture chamber
when using FGF-2-containing media, similar to that found
in vivo.
In vitro scaling-up of the 3-D vascularized tissue. To scale-up
production of bioengineered tissues, we have already demon-
strated one possible solution in vivo. Multiple transplantation of
triple-layer cell sheets produced thicker tissues under in vivo
conditions18. Therefore, to scale-up in vitro, triple-layer
cocultured cardiac cell sheets could be repeatedly overlaid on
the vascular bed and perfused using the bioreactor system. A
second triple-layer tissue was overlaid on the first graft after
3 days cultivation and the whole construct was perfused for a
further 3 days (Fig. 4a). By comparison, a six-layer cell sheet
tissue was overlaid on the vascular bed and cultured for 6 days
(Fig. 4b). Although blood cells perfused at the end of the
cultivation were able to reach the cardiac tissues in both
procedures, the two-step procedure produced thicker and more
cell-dense cardiac tissues than the single-step six-layer procedure
(Fig. 4c–f). Some cells became necrotic in the single-step six-layer
procedure, because of the primary diffusion limit of oxygen and
nutrition and waste accumulation within the six-layer tissues. On
the other hand, allowing time for functional neovascularization
within the first triple-layer tissue produces a sufficient vascular
bed for the second triple-layer, so that the final six-layer tissue
was totally vascularized without any necrosis. Bioluminescent
imaging analyses using luciferase-expressing cell sheets also
clearly demonstrated greater tissue survival in the two-step
procedure than in the single-step procedure (n¼ 4, Fig. 4g–i;
Supplementary Movie 6). A thick 12-layer construct is produced
by overlaying triple-layer cell sheets four times on a vascular bed
(Fig. 4j). This successful procedure has opened up a new
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Figure 4 | Double-step overlaying of triple-layer cell sheets and viability assay. (a) The double-step overlaying is schematically illustrated. Triple-layer
cocultured cardiac cell sheets are overlaid on the vascular bed and perfused. After 3 days of cultivation, to provide sufficient vascularization within the first
graft, the second triple-layer tissue is overlaid on the first graft and the construct is perfused for a further 3 days. Finally, the whole construct is thoroughly
vascularized. (b) The single-step overlaying with six-layer cell sheets is schematically illustrated. Six-layer cell sheet tissues are overlaid, in one step, on the
vascular bed and perfused for 6 days. (c,d) HE and Azan staining for blood-perfused double-step constructs showed that blood cells well reached the six-
layer cell sheets (white arrows) and that thicker and more cell-dense tissue was successfully fabricated. (e,f) HE and Azan staining for blood cell-perfused
one-step constructs shows some necrotic cells (black arrow heads) and relatively cell-sparse tissues. (g–i) After continuous luciferin infusion, serial
bioluminescent imaging of each group was analysed. The images captured at 60min are shown (g,h). The intensity from the double-step procedure was
significantly higher than that from the single-step procedure (i). Data are shown as mean±s.d. (*Po0.05) (n¼4). Triple-layer cell sheets are overlaid four
times on the vascular bed to produce a thick 12-layer construct (j).
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possibility for scaling-up the production of bioengineered tissues
in vitro.
In vivo survival of beating cardiac tissues. Our next step was to
transplant in vitro bioengineered vascularized tissue in vivo. The
six-layer tissue graft, engineered by the double-step overlaying of
triple-layer luciferase-expressing cell sheets, was removed from
the bioreactor system after a 6-day cultivation, and transplanted
in the neck of a nude rat. The protruding femoral artery and vein
of the graft were then reconnected to the carotid artery and the
jugular vein, respectively, by a cuff technique as previously
reported (Fig. 5a); ref. 19. By comparison, six-layer grafts with
vascular beds were transplanted without vessel anastomoses
(Fig. 5b), and also six-layer cell sheets without a vascular bed were
simply transplanted (Fig. 5c). In vivo imaging of bioluminescence
revealed the highest viability in cases of grafting via blood vessel
anastomoses (Fig. 5d–g, n¼ 4). On the other hand, the viabilities
were very low in both the grafts without vessel anastomoses
and in the simple six-layer constructs without a vascular bed,
indicating that tissue necrosis was due to primary ischaemia
(Fig. 5e–g). The vascularized graft with blood vessel anastomoses
also maintained its vascular structure and beating for 2 weeks
after the procedure (Fig. 5h). It showed the uniform distribution
of ECs and the characteristics of a micro blood vessel (Fig. 5i,j).
This successful grafting demonstrated the clinical potential of
transplanting in vitro bioengineered tissues with connectable and
functional AV networks.
Discussion
Here we have fabricated functional 3-D cardiac tissues in vitro
with perfusable vascular networks using cell-sheet-based tissue
engineering and a novel bioreactor system. The advantage of cell
sheet technology is the direct cell-to-cell communications
between cell sheets and between a cell sheet and a host tissue,
which initiate electrical communications and vascular network
formation within the engineered tissues. Various types of
extracellular matrix and membrane proteins, including fibronec-
tin and integrin, are preserved underneath the cell sheets and
act as adhesive agents when cell sheets are stacked on each other
or transferred onto other tissues20. Cardiac cell sheets
communicate electrically within 30min via fast gap junction
formation, and the EC networks within cell sheets also
communicate between cell sheets21–23. In this study, the
cocultured ECs and the direct attachment of the cell sheet onto
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Figure 5 | Transplantation of in vitro vascularized cardiac tissues. (a) The six-layer tissue graft engineered by the double-step procedure was removed
from the bioreactor system and transplanted in the neck of a nude rat with anastomosis between the protruding femoral vessels of the graft and the
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the vascular bed might have initiated the formation of the
functional vascular network between the cell sheets and the
vascular bed. The experiments using GFP-expressing cells clearly
revealed that cocultured ECs within cell sheets migrated into the
vascular bed and connected to its blood vessels. In addition,
media perfusion through the blood vessels in the vascular bed
probably triggered the tubular structure formation in the EC
network of the cell sheets, just as observed after in vivo cell sheet
transplantation. Several studies have reported the possibility of
in vitro functional blood vessel formation, however, completely
perfusable blood vessel formation within cell-dense tissues has
not been reported24–27. Although preformed 3-D scaffolds,
including microcapillary lumens, may realize a native tissue-like
structure, high-density cell seeding is difficult and leaky blood
vessels are problematic. We believe that trying to mimic the
natural regenerative growth in organs is a better approach to
tissue engineering. Therefore, the simultaneous reconstruction of
tissues together with their own blood vessels may be more
appropriate for cell-dense tissue fabrication. From this point of
view, the present step-by-step procedure based on cell sheet
stacking technology seems to be feasible for in vitro fabrication of
viable tissues with an appropriate vascular network formation
that can be scaled up.
In this study, serial bioluminescent imaging contributed to
important information about media supply dynamics, in addition
to tissue viability. Regarding in vivo imaging, luminescent
intensity increased faster and the peak came earlier in luciferin
infused via blood vessels than through intraperitoneal infusion.
This indicates that the direct supply of luciferin through blood
vessels initiates a rapid response, but that gradual diffusion
through the tissues causes a delayed response28. Similarly, the
present data revealed an earlier start of bioluminescent intensity
in the cocultured constructs than in the non-cocultured
constructs, and therefore we considered that perfusable blood
vessel communications had developed between the cell sheet
construct and the vascular bed. In contrast to the black ink
perfusion throughout the FGF-treated, cocultured constructs, the
ink was hardly detected in most cross-sections of the non-FGF-2-
treated, cocultured constructs (Fig. 2c), and only partial perfusion
was occasionally observed in some sections (Fig. 2q). Therefore,
the numerous blood vessel connexions due to FGF-2 treatment
might have contributed to the rapid media flow through newly
formed blood vessels and the early and fast increase in
luminescence. On the other hand, partial blood vessel
communications in the non-FGF-2-treated constructs might
have caused stagnant media flow in the blood vessel structure,
leading to the early but slow increase of signals.
We have repeated the procedure up to four times and
successfully fabricated a 12-layer construct (Fig. 4j), however,
the thickness does not increase linearly in accordance with the
number of layered cell sheets. When multi-step procedures are
performed with the same cultivation conditions, uniform
perfusion may be insufficient for whole-tissue survival, resulting
in a reduction in the thickness of the final tissue. It seems that at
least the flow rate should be increased in accordance with tissue
mass to increase the thickness. Moreover, the periods required for
sufficient neovascularization within the first triple-layer cell sheets
in vivo and in vitro are 1 and 3 days, respectively. This significant
gap is considered to be caused by the differences in the
composition of the liquids perfused, blood vessel pressure and
surrounding atmosphere conditions. Therefore, further biological
and mechanical optimization should also accelerate vascular
formation and improve the efficiency of scaling-up.
In this study, 3-D pulsatile cardiac tissues including a
completely perfusable AV loop were developed. By using a native
vascular bed with surgically connectable artery and vein, in vitro
bioengineered vascularized tissues were retransplanted with blood
vessel anastomoses and survived in vivo. In clinical applications,
candidates for vascular beds could include an antero lateral thigh
flap with the descending branches of the lateral circumflex
femoral artery and vein, or a serratus flap with the branches of the
dorsal thoracic artery and vein. For engineering large-scale
cardiac tissues, cardiomyocytes differentiated from embryonic
stem and induced pluripotent stem cells may be future possible
cell sources. We have already established the technology for
expanding human induced pluripotent stem cell-derived cardio-
myocytes and have successfully made cell sheets with them29. The
size and shape of cell sheets can also be controlled by culture
surface modification. Future optimization of human resectable
tissues including a thick artery and vein, a human implantable
cardiac cell source and perfusion culture conditions may allow
in vitro fabrication of clinically transplantable large-scale tissue.
These constructs are also useful for basic biology and drug
screening as in vitro models. The connectable artery and vein is
helpful for drug administration into tissues, which can mimic
in vivo conditions and may be an alternative to animal
experiments.
In conclusion, we have shown that the in vitro construction
of perfusable blood vessel within viable cell-dense tissues is
possible, that these are suitable for subsequent transplantation
and that their production can be scaled up. This technique for
in vitro tissue engineering may be applied to many other tissue
types than the cardiac tissue demonstrated here, and may
facilitate the discovery of new biological and medical insights,
as well as lead to further advances in tissue engineering and its
potential therapeutic application.
Methods
All animal experiments were performed according to the ‘Guidelines of Tokyo
Women’s Medical University on Animal Use’.
Vascular bed fabrication. An engineered vascular bed to promote angiogenesis
was made from rat femoral muscle, which included an artery and vein. Fischer 344
athymic rats (250–350 g, male, Charles River Japan, Tokyo, Japan) and GFP-
expressing Sprague-Dawley (SD) neonatal rats (SD-TgN [Act-EGFP] OsbCZ-004,
SLC, Hamamatsu, Japan) were anesthetized with 2% inhaled isoflurane. The rat
femoral muscle tissue was partially resected from the surrounding tissue and
peripheral blood vessels by using a thermal cautery unit (TCU-150, Bio Research
Center, Nagoya, Japan). The tissue including the artery and vein was reset to the
original position. One week after the incubation in the host body, the whole
construct was resected together with the femoral artery and vein under anaesthesia
and heparinization (400 IU kg 1, intravenous injection). The blood in the con-
struct was washed out with lactated ringer’s solution. Rats were then euthanized
with overdoses of pentobarbital.
Bioreactor set-up and tissue perfusion culture. The bioreactor is a one-pass
system consisting of a microprocessor-controlled delivery pump (IPC-N, ISMA-
TEC, Germany), a custom-made tissue culture chamber (Tokai Hit, Shizuoka,
Japan), a pH probe (ABLE, Tokyo, Japan), a dissolved oxygen probe (ABLE), a pH
transmitter (ABLE), flow transmitter (ABLE), a pressure transmitter (Edwards
Lifesciences, Tokyo, Japan), CO2 gas flow controllers and a data acquisition system
(ABLE). A glove box was used to maintain a temperature of 37 1C (AS ONE,
Tokyo, Japan). The tubing used for connexions was Micro-Renathane (I.D. 0.3 and
0.6mm, Bio Research Center) and the pump tubing was Pharmed Ismaprene (I.D.
1.3mm, ISMATEC). The pH conditions were measured and controlled via a
process controller to verify the concentration of CO2 gas in the media reservoir.
The outlet waste media volumes were measured by electrical balance (A&D, Tokyo,
Japan). The vascular bed was placed in a tissue culture chamber and perfused with
culture media including 6% fetal bovine serum at 50 ml min 1 by the delivery
pump through the inlet tube connected to the femoral artery. The data of pH,
temperature, arterial pressure and perfused media volume were recorded during
the cultivation. For enhancement of neovascularization, 16 ngml 1 rat FGF-2
(PeproTech, Rocky Hill, NJ) was added into the culture media.
Cell sheet fabrication. Cardiac cells were isolated from the ventricles of 1-day-old
SD neonatal rats (SLC), GFP-positive SD neonatal rats (SLC) and firefly luciferase-
expressing Lewis neonatal rats (LEW-Tg [Rosa-luc] 11 jmsk) according to pre-
viously described procedures11. Endothelial cells (ECs) were separated from
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primary myocardial cell suspensions by magnetic cell sorting (Miltenyi Biotech
GmbH, Bergisch Gladbach, Germany) using mouse monoclonal anti-rat CD31
antibody (MCA1334G, Serotec Ltd., Oxford, UK), as previously described13. To
fabricate cocultured cardiac cell sheets, GFP-negative cardiac cells without ECs and
purified GFP-positive ECs were mixed at a ratio of 4:1, and were cultured at a
density of 2.4 106 cells on 35-mm temperature-responsive culture dishes
(CellSeed, Inc., Tokyo, Japan) at 37 1C in a humidified atmosphere containing 5%
CO2. After 4 days, the cocultured cardiac cells were transferred to another
incubator set at 20 1C for 1 h, to release the cultured cells as intact sheets.
Stacking and transfer to the vascular bed. The cardiac cell sheets, which
detached spontaneously from temperature-responsive culture dishes, were sus-
pended in the aqueous media. To layer the cell sheets, one cell sheet with culture
media was gently aspirated into the tip of a pipette and transferred onto a new
temperature-responsive culture dish. After dropping culture media to smoothly
spread the cell sheets, the dishes were incubated at 37 1C for 30min to allow for the
cell sheet to adhere to the culture surface. Then a second cell sheet was placed on
top of the first and attached by aspiration of the media. After incubation at 37 1C
for 30min, triple-layer constructs were finally created using the same procedures.
Triple-layer cardiac cell sheets were overlaid on the vascular bed perfused within
the bioreactor system. The second triple-layer cardiac cell sheets were overlaid on
the first graft after cultivation for 3 days and then the whole construct was further
perfused for an additional 3 days. Further multi-step layering was performed by the
same procedure.
Morphological analyses. For cross-sectional observation, tissues were fixed in 4%
paraformaldehyde and routinely processed into 7-mm-thick paraffin-embedded
sections. HE staining and Azan staining was performed using conventional
methods. For the detection of ECs, deparaffinized sections were incubated with
both a 1:200 dilution of anti-GFP mouse monoclonal antibody (Life Technologies,
Carlsbad, OR) and a 1:100 dilution of anti-CD31 rabbit polyclonal antibody (Life
Technologies) overnight at 4 1C. For the detection of cardiomyocytes, sections were
incubated with a 1:200 dilution of anti-sarcomeric a-actinin mouse monoclonal
antibody (Sigma, St Louis, MO) for 2 h. For the detection of smooth muscle cells,
sections were incubated with a 1/100 dilution of anti-calponin mouse monoclonal
antibody (Acris Antibodies, Herford, Germany). Specimens were then treated with
both a 1:200 dilution of Alexa-Fluor-488-conjugated anti-rabbit IgG antibodies
(Life Technologies) and Alexa-Fluor-568 conjugated anti-mouse IgG antibodies
(Life Technologies) for 2 h at room temperature. Cell nuclei were then counter-
stained by ProLong Gold antifade reagent with DAPI (Life Technologies) for 5min.
Sections were finally visualized using confocal laser-scanning microscopy (LSM 510
META; Carl Zeiss, Jena, Germany).
Analyses of media supply dynamics and tissue survival. A custom-made
electron multiplying-CCD camera system and AquaCosmos 2.6 software (Ima-
geEM, Hamamatsu Photonics, Shizuoka, Japan) were used for real-time biolumi-
nescent imaging during the cultivation. Samples were placed into the light-tight
chamber of the CCD camera system, and a grayscale surface image was taken
under weak illumination. For the in vitro study, the cultivated tissue was con-
tinuously perfused with 0.1% D-luciferin firefly potassium salt (Promega, Madison,
WI) at 50 ml min 1 in the bioreactor system. For the in vivo study, rats were
anesthetized with 2% inhaled isoflurane, and 500ml of 3.3% D-luciferin firefly
potassium salt was injected into the superficial dorsal vein of the penis 2min before
imaging. The photon intensity of the cell sheet constructs was expressed as total
flux, in units of photons per second. For anatomical localization, a pseudo colour
image representing the light intensity (blue, least intense; red, most intense) was
generated in Living Image and superimposed over the grayscale reference image.
Image acquisition with two-photon laser-scanning microscopy. The newly
formed vessels were imaged using a two-photon laser-scanning microscopy system
with FLUOVIEW version 3.1 software (FV1000MPE, Olympus, Tokyo, Japan)
employing X25 objective lens (XLPLN25XWMP, numerical aperture¼ 1.05,
working distance¼ 2.0mm). The brightness compensation function in the
z direction was used to change the detector sensitivity and laser power. The con-
tribution of cocultured ECs was determined by detecting GFP signals from
fluorescent images obtained after the constructs were finally perfused with 1%
tetramethylrhodamine dextran (MW 2 million, Life Technologies) at 50 ml min 1
or 2% red fluorescent microspheres suspended in media (FluoSpheres, 4 mm in size,
Life Technologies) at 50ml min 1. A series of XY images through the 3-D
reconstruction data (500 500 200 mm volume) were obtained.
Fabricated 3-D tissue transplantation to the neck. To pursue the possibility of
ectopic transplantation, separate F344 athymic rats (250–350 g, male, Charles River
Japan) were anesthetized with 2% inhaled isoflurane and skin incisions were made
in the neck to expose the underlying tissue. The common carotid artery and the
jugular vein were exposed and isolated from their peripheries, and then clamped to
prevent subsequent bleeding. The in vitro engineered constructs were connected to
the neck vessels by a cuff technique as previously reported17. Briefly, the femoral
artery and vein were introduced into 22 and 21-gauge cuffs, respectively, and were
everted and secured with circumferential 6-0 silk sutures. The carotid artery and
the jugular vein were gently slipped over the cuff that had been fixed to the femoral
artery and vein, and secured again with circumferential 6-0 silk sutures. After the
clamps were removed and the graft beating was confirmed, the incision was closed.
After 2 weeks the survival of the graft was examined using the bioluminescent
imaging system and then the rats were euthanized.
Video capture. Macroscopic images of pulsatile myocardial tissue grafts were
recorded by a motion analysing microscope (VW5000, KEYENCE, Tokyo, Japan).
The videos were edited with Adobe Premiere Pro 4.0 software.
Data analysis. All data are expressed as mean±s.d. An unpaired Student’s t-test
was performed to compare the two groups. One-way analysis of variance was used
for multiple group comparisons. If the F-distribution was significant, a Fisher’s
LSD test was used to specify differences between groups. A P-value of o0.05 was
considered significant.
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